LunaDNA, founded by Luna Public Benefit Corporation (LunaPBC) is a community-owned platform for health research. Anyone can join, share their health data, and receive ownership shares in the company. When researchers conduct studies on the data in our secure platform, the proceeds are passed back to the community as dividends.
LunaDNA was created by LunaPBC, a team of passionate genomics and technology veterans. LunaPBC is responsible for managing the LunaDNA platform, including developing research projects with non-profits and for-profits to make medical discoveries with the health data on the platform.
The LunaPBC team holds integrity, honesty, and transparency as top values. We are passionate about science, technology, and the promise they hold for medicine.
Inspired by life experiences to improve health and quality of life for everyone
Sharing a deep-rooted desire to solve important problems for the greater good of humanity
Creating an opportunity for all stakeholders by establishing a community based on understanding, authenticity, honesty, and transparency
Making a people-centered platform that reflects the diversity seen all over the world
Chief Executive Officer & Co-Founder
Bob Kain is a renowned pioneer in genomics. At Illumina, Bob led the invention of the modern, high throughput genome sequencer that brought the cost from millions of dollars down to less than $1000.
He joined Illumina pre-IPO in 1999 and retired in 2014, as the Chief Engineering Officer. Bob is lead inventor on 28 U.S. patents that led to the breakthroughs that have revolutionized genome sequencing. Prior to joining Illumina, Bob was the Director of the Microarray Business Unit at Molecular Dynamics. He is also on the Scientific Advisory Boards of Dovetail Genomics, Singular Genomics, and Edenroc Biosecurity, and is the co-founder of Revere Biosensor. Additionally, he is the co-founder and chairman of the board of a successful health & fitness business, Mesa Rim Climbing and Fitness Center, with multiple locations in San Diego and Reno, Nevada.
Bob received a BS in Physics from San Diego State University and an MBA from Saint Mary’s College of California.
President & Co-Founder
Dawn served as the Vice President of Applied Genomics at Illumina, Inc. Dawn integrated market development strategies with product and business model innovation to accelerate the application of genomics in medicine and personal healthcare. Dawn joined Illumina in 2005.
Prior to Illumina, Dawn spent seven years at Genaissance Pharmaceuticals, one of the first genomics startups focused on individualized medicine and DNA-based diagnostic testing.
She holds a BS in biology from the University of Vermont and a MBA from the University of Connecticut School of Business.
Scott Kahn, Ph.D
Chief Information Officer, Former CIO and VP of Commercial and Enterprise Informatics at Illumina
Chief Financial Officer & Co-Founder, Chief Investment Officer & Co-Founder at Ganley Investments, Former Citigroup Executive
Vice President, Strategy & Business Operations, Former Director, Market Strategy and Innovation, Clinical Genomics at Illumina
Head of Dev Ops & Automation, Former Sr. DevOps Architect, Clinical Genomics at Illumina
Representing seasoned healthcare and patient advocates, data scientists, and consumer engagement leaders, our advisory board exemplifies the expertise needed to help build a member-centric, future-focused Public Benefit Corporation.
Co-Founder, CTO & Co-Founder of Redemption Games, Blockchain Developer and Y Combinator Alumni
Ashley Van Zeeland, Ph.D
Advisor, VP, Product Development Business Operations & Systems Integration at Illumina, Former CTO at Human Longevity, Former Co-Founder Cypher Genomics
Carlos Bustamante, Ph.D
Advisor, Professor of Biomedical Data Science and Genetics at Stanford University
Aristides A.N. Patrinos, Ph.D
Advisor, Former President Synthetic Genomics, Lead at Human Genome Project
Advisor, Founder & CEO of Reneo Capital healthcare fund; former VP Amylin Pharmaceuticals
LunaPBC is backed by leading healthcare and technology investors including:
Biotech VC Fund
Arch Venture Partners
Biotech VC Fund
Future-Tech VC Fund
UK Tech VC Fund
CEO of Prelude Capital
Co-Founder of Illumina